Triple

T18784284
Position Surface form Disambiguated ID Type / Status
Subject Notch E459333 entity
Predicate requiresProcessingBy P82893 FINISHED
Object ADAM-family metalloprotease NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ADAM-family metalloprotease | Statement: [Notch, requiresProcessingBy, ADAM-family metalloprotease]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: ADAM-family metalloprotease
Context triple: [Notch, requiresProcessingBy, ADAM-family metalloprotease]
  • A. MT1-MMP (via BT1718)
    MT1-MMP (via BT1718) is a membrane-bound matrix metalloproteinase exploited by the Bicycle Therapeutics drug candidate BT1718 as a tumor-targeting antigen for selective delivery of cytotoxic payloads to cancer cells.
  • B. ase
    "ase" is the ISO 639-3 language code assigned to American Sign Language, the primary sign language used by Deaf communities in the United States and parts of Canada.
  • C. Activase
    Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
  • D. Serpins
    Serpins is a civil parish in the municipality of Lousã in central Portugal, known for its natural landscapes and proximity to the Serra da Lousã.
  • E. ACE2
    ACE2 is a human cell-surface enzyme and receptor that plays a key role in regulating blood pressure and serves as the primary entry point for SARS-CoV-2 into host cells.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: ADAM-family metalloprotease
Target entity description: ADAM-family metalloproteases are membrane-anchored enzymes that cleave and activate various cell-surface proteins, playing key roles in processes such as cell signaling, development, and inflammation.
  • A. MT1-MMP (via BT1718)
    MT1-MMP (via BT1718) is a membrane-bound matrix metalloproteinase exploited by the Bicycle Therapeutics drug candidate BT1718 as a tumor-targeting antigen for selective delivery of cytotoxic payloads to cancer cells.
  • B. ase
    "ase" is the ISO 639-3 language code assigned to American Sign Language, the primary sign language used by Deaf communities in the United States and parts of Canada.
  • C. Activase
    Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
  • D. Serpins
    Serpins is a civil parish in the municipality of Lousã in central Portugal, known for its natural landscapes and proximity to the Serra da Lousã.
  • E. ACE2
    ACE2 is a human cell-surface enzyme and receptor that plays a key role in regulating blood pressure and serves as the primary entry point for SARS-CoV-2 into host cells.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8d396f54c8190ba49db31e8743842 completed April 10, 2026, 10:40 a.m.
NER Named-entity recognition batch_69e5977ffa648190be5f682bba47fb0a completed April 20, 2026, 3:03 a.m.
Created at: April 10, 2026, 11:52 a.m.